Select Publications

Journal articles

Hickie IB; Bennett BK; Lloyd AR; Heath A; Martin N, 1999, 'Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: a twin study.', Psychological Medicine, pp. 269 - 277

Di Girolamo N; Tedla NT; Kumar RK; Mccluskey P; Lloyd AR; Coroneo MT; Wakefield D, 1999, 'Culture and characterisation of epithelial cells from human pterygia', British Journal of Ophthalmology, pp. 1077 - 1082

Verma MJ; Mukaida N; Vollmer-Conna US; Matsushima K; Lloyd AR; Wakefield D, 1999, 'Endotoxin induced uveitis is partially inhibited by AntiIL8 antibody treatment', Investigative Ophthalmology and Visual Science, pp. 2465 - 2470

Tedla NT; Dwyer JM; Truskett PG; Taub DD; Wakefield D; Lloyd AR, 1999, 'Phenotypic and functional characterisation of lymphocytes derived from normal and HIV1 infected human lymph nodes.', Clinical and Experimental Immunology, 117, pp. 92 - 99

Koschera A; Hickie IB; Hadzi-Pavlovic D; Wilson AR; Lloyd AR, 1999, 'Prolonged fatigue, anxiety and depression: exploring relationships in a primary care sample.', Australian and New Zealand Journal of Psychiatry, pp. 545 - 552

Wakefield D; Cuello C; Di Girolamo N; Lloyd AR, 1999, 'The role of cytokines and chemokines in uveitis', Developments in Ophthalmology, pp. 53 - 66

Hickie IB; Koschera A; Hadzi-Pavlovic D; Bennett BK; Lloyd AR, 1999, 'The temporal stability and comorbidity of prolonged fatigue: a longitudinal study in primary care.', Psychological Medicine, pp. 855 - 861

Haber PS; Parsons S; Harper S; White PA; Rawlinson WD; Lloyd AR, 1999, 'Transmission of hepatitis C within Australian prisons.', Medical Journal of Australia, 171, pp. 31 - 33

O'Riordan JM; Conroy A; Nourse C; Yap PL; McDonald GSA; Kaminski G; Leong K; Lawlor E; Davoren A; Strong K; Davidson F; Lloyd A; Power J, 1998, 'Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C', Transfusion Medicine, 8, pp. 303 - 308, http://dx.doi.org/10.1046/j.1365-3148.1998.00172.x

Kelly MD; Naif HM; Adams SL; Cunningham AL; Lloyd AR, 1998, 'Cutting edge: Dichotomous effects of β-chemokines on HIV replication in monocytes and monocyte-derived macrophages', Journal of Immunology, 160, pp. 3091 - 3095

Trickett AE; Kelly M; Cameron BA; Lloyd A; Ffrench RA; Dwyer JM, 1998, 'A preliminary study to determine the effect of an infusion of cryopreserved autologous lymphocytes on immunocompetence and viral load in HIV-infected patients', J Acquir Immune Defic Syndr Hum Retrovirol, 17, pp. 129 - 136

Naif H; Li S; Alali M; Sloane A; Wu L; Kelly M; Lynch G; Lloyd AR; Cunningham AL, 1998, 'CCR5 expression correlates with susceptibility of maturing monocytes to Human Immunodeficiency Virus type 1 infection.', Journal of Virology, pp. 830 - 836

Cuello C; Palladinetti P; Tedla NT; Di Girolamo N; Lloyd AR; Mccluskey P; Wakefield D, 1998, 'Chemokine expression and leucocyte infiltration in Sjögren's syndrome', British Journal of Rheumatology, pp. 779 - 783

Lloyd AR, 1998, 'Chronic fatigue and chronic fatigue syndrome: Shifting boundaries and attributions.', American Journal of Industrial Medicine, 105, pp. 7S - 10S

Vollmer-Conna US; Lloyd AR; Hickie IB; Wakefield D, 1998, 'Chronic fatigue syndrome: an immunological perspective', Australian and New Zealand Journal of Psychiatry, pp. 523 - 527

Kelly M; Hassan M; Adams SE; Cunningham AL; Lloyd AR, 1998, 'Dichotomous effects of b-chemokines on HIV-1 replication in monocytes and monocyte-derived macrophages.', Journal of Immunology, 160, pp. 3091 - 3095

Di Girolamo N; Tedla NT; Lloyd AR; Wakefield D, 1998, 'Expression of matrix metalloproteinases by human plasma cells and B lymphocytes.', European Journal of Immunology, pp. 1773 - 1784

Mikloska Z; Danis V; Adams SE; Lloyd AR; Adrian DL; Cunningham AL, 1998, 'In vivo production of cytokines and b (C-C) chemokines in human recurrent herpes simplex lesions - do herpes simplex virus-infected keratinocytes contribute to their production?', Journal of Infectious Diseases, 177, pp. 827 - 838

O Donnell MC; Catts SV; Ward PB; Liebert BJ; Lloyd AR; Wakefield D; McConaghy N, 1998, 'Interleukin-2 and schizophrenia', Psychiatry Research, 77, pp. 65 - 66, http://dx.doi.org/10.1016/S0165-1781(97)00130-3

Wang H; Tedla NT; Lloyd AR; Wakefield D; McNeil HP, 1998, 'Mast cell activation and migration to lymph nodes during induction of an immune response in mice.', Journal of Clinical Investigation, 102, pp. 1617 - 1626

Carr AD; Emery S; Lloyd AR; Hoy JF; Garsia R; French MA; Stewart GA; Fyfe G; Cooper DA, 1998, 'Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, milticenter study', Journal of Infectious Diseases, 178, pp. 992 - 999, http://jid.oxfordjournals.org/content/178/4/992.full.pdf+html

Tedla NT; Wang H; McNeil HP; Di Girolamo N; Hampartzoumian T; Wakefield D; Lloyd AR, 1998, 'Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1alpha and MIP-1beta.', Journal of Immunology, 161, pp. 5663 - 5672

Bennett BK; Hickie IB; Vollmer-Conna US; Quigley B; Brennan CM; Wakefield D; Douglas MP; Hansen GR; Tahmindjis AJ; Lloyd AR, 1998, 'The relationship between fatigue, psychological and immunological variables in acute infectious illness.', Australian and New Zealand Journal of Psychiatry, pp. 180 - 186

Verma MJ; McCluskey P; Matsushima K; Mukaida N; Lloyd A; Wakefield D, 1997, 'Inhibitory effect of anti-IL-8 antibody on endotoxin induced uveitis', INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 38, pp. 4418 - 4418, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WN21501240&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tedla N; Wang HW; McNeil HP; Wakefield D; Lloyd A, 1997, 'Chemokines regulate T cell recruitment to lymph nodes during contact hypersensitivity.', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 99, pp. 1006 - 1006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WH14201003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Di Girolamo N; Visvanathan K; Lloyd A; Wakefield D, 1997, 'Expression of TNF-α by human plasma cells in chronic inflammation', Journal of Leukocyte Biology, 61, pp. 667 - 678, http://dx.doi.org/10.1002/jlb.61.6.667

Verma MJ; Lloyd AR; Rager H; Strieter R; Kunkel S; Taub DD; Wakefield D, 1997, 'Chemokines in acute anterior uveitis', Current Eye Research, 16, pp. 1202 - 1208

Adams D; Lloyd AR, 1997, 'Chemokines: leucocyte recruitment and activation cytokines', Lancet, pp. 490 - 495

Vollmer-Conna US; Wakefield D; Lloyd AR; Hickie IB; Lemon J; Bird KD; Westbrook RF, 1997, 'Cognitive deficits in patients suffering from chronic fatigue syndrome, acute infective illness or depression', British Journal of Psychiatry, 171, pp. 377 - 381

Di Girolamo N; Visvanathan K; Lloyd AR; Wakefield D, 1997, 'Expression of tumor necrosis factor-alpha by human plasma cells in chronic inflammation', Journal of Leukocyte Biology, pp. 667 - 678

Lloyd AR, 1997, 'How to cope with chronic fatigue', Medical Journal of Australia, 167, pp. 487 - 488, http://dx.doi.org/10.5694/j.1326-5377.1997.tb126680.x

Di Girolamo N; Lloyd AR; Mccluskey P; Filipic M; Wakefield D, 1997, 'Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts', American Journal of Pathology, 150, pp. 653 - 666

Stewart GA; Ashton LJ; Biti RA; Ffrench FA; Bennetts BH; Newcombe NR; Benson EM; Carr AD; Cooper DA; Kaldor JM; Smith DD; Catchpole BR; Allworth A; Baker D; Batty G; Beveridge A; Bloch M; Bodsworth NJ; Clare K; Cummins E; Cunningham PH; Couldwell D; Deacon N; Doong N; Finlayson R; Furner V; Huffam SE; Kidd J; Kelly MD; Lloyd AR; Mcfarlane R; Mclean K; Mcnulty A; Mcphee D; Michelmore H; Mcmurchie M; Mutimer K; Peterson J; Price R; Quan J; Qurn J; Ree H; Robertson M; Roggensack M; Schroeder K; Spencer D; Sullivan JS; Ziegler JB, 1997, 'Increased frequency of CCR-5 delta32 heterozygotes among long-term nonprogressors with HIV infection.', AIDS, 11, pp. 1833 - 1838

Vollmer-Conna US; Hickie IB; Hadzi-Pavlovic D; Tymms K; Wakefield D; Dwyer JM; Lloyd AR, 1997, 'Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome', American Journal of Medicine, 103, pp. 38 - 43

Catts SV; Lloyd AR; Huang XF; Dixon GJ; Chahl L; Harper C; Wakefield D; Ward PB, 1997, 'Molecular biological investigations into the role of the NMDA receptor in the pathophysiology of schizophrenia', Australian and New Zealand Journal of Psychiatry, pp. 17 - 26

Khachigian LM; Dixon GJ; Huang XF; Catts SV; Hickie IB; Wakefield D, 1997, 'Molecular biology and the major psychoses', Australian and New Zealand Journal of Psychiatry, pp. 12 - 16

Hickie IB; Lloyd AR; Halliday GM; Mcritchie DA; Scott E; Mitchell PB; Wakefield D, 1997, 'Utilising molecular biological and histopathological techniques to study the dopaminergic system in patients with melancholia', Australian and New Zealand Journal of Psychiatry, pp. 27 - 35

Lloyd A, 1996, 'HIV infection and AIDS', Papua and New Guinea Medical Journal, pp. 174 - 180

Kelly MD; Lloyd AR; Kemp RJ, 1996, '5.17 HIV, weight loss and wasting syndrome', Medical Journal of Australia, 164, pp. 549 - 550, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122170.x

Kelly MD; Lloyd AR; Kemp RJ, 1996, 'Treating secondary outcomes .5. HIV, weight loss and wasting syndrome', MEDICAL JOURNAL OF AUSTRALIA, 164, pp. 549 - 550, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122170.x

Lloyd AR; Oppenheim JJ; Kelvin DJ; Taub DD, 1996, 'Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins', Journal of Immunology, 156, pp. 932 - 938

Sayers TJ; Lloyd AR; Mcvicar DW; O Connor MD; Kelly J; Carter C; Carter CR; Wiltrout TA; Wiltrout RH; Smyth MJ, 1996, 'Cloning and expression of a second human natural killer cell granule tryptase, HNK-Tryp-2/ granzyme 3', Journal of Leukocyte Biology, pp. 763 - 768

Hickie IB; Hooker A; Hadzi-Pavlovic D; Bennett BH; Wilson AR; Lloyd AR, 1996, 'Fatigue in selected primary care settings: socio-demographic and psychiatric correlates', Medical Journal of Australia, 164, pp. 585 - 588

Hickie IB; Hooker A; Hadzi-Pavlovic D; Bennett BH; Wilson AR; Lloyd AR, 1996, 'Fatigue in selected primary care settings: sociodemographic and psychiatric correlates', Medical Journal of Australia, 164, pp. 585 - 588

Digirolamo N; Verma MJ; Mccluskey P; Lloyd AR; Wakefield D, 1996, 'Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis', Current Eye Research, 15, pp. 1060 - 1068

O Donnell MC; Catts SV; Ward PB; Liebert B; Lloyd AR; Wakefield D; McConaghy N, 1996, 'Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder', Psychiatry Research, pp. 171 - 178

Hickie IB; Lloyd AR; Wakefield D; Ricci C, 1996, 'Is there a post-infectious fatigue syndrome?', Australian Family Physician, pp. 1847 - 1852

HUANG XF; DIXON G; CATTS SV; WARD PB; WAKEFIELD D; LLOYD A, 1995, 'THE NMDA RECEPTOR COMPLEX IN THE HIPPOCAMPUS IN SCHIZOPHRENIA', SCHIZOPHRENIA RESEARCH, 15, pp. 60 - 60, http://dx.doi.org/10.1016/0920-9964(95)95190-K

LLOYD A; TEDLA N; PALLADINETTI P; KELLY M; TRUSKETT P; COOKE B; DWYER J; WAKEFIELD D, 1995, 'T-CELL RECRUITMENT TO THE LYMPH-NODE OF PATIENTS WITH HIV AND HEALTHY CONTROL SUBJECTS - THE ROLE OF CHEMOKINES', FASEB JOURNAL, 9, pp. A202 - A202, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995QL98701199&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hickie I; Hickie C; Bennett B; Wakefield D; Silove D; Mitchell P; Lloyd A, 1995, 'Biochemical correlates of in vivo cell-mediated immune dysfunction in patients with depression: A preliminary report', International Journal of Immunopharmacology, 17, pp. 685 - 690, http://dx.doi.org/10.1016/0192-0561(95)00055-7


Back to profile page